MedTrace Logo

The Feasibility of a Facebook Group-based Program for Foot Self-management Support of Adults With Diabetes in Canada

NCT04395521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-03-23

No results posted yet for this study

Summary

The primary objective of this study is to examine the feasibility of a Facebook group-based program to support adults with diabetes in their foot self-care and prevention of foot ulcers.

The sub-objectives are:

1\. To determine the recruitment and retention rate of participants in the study. 2. To assess the acceptability of the Facebook group program among participants. 3. To determine the level and pattern of engagement by the participants within the Facebook group platform. 4. To determine the efficacy of the Facebook group program and how it works to improve diabetic foot care-related outcomes.

Conditions

  • Diabetic Foot Ulcer

Interventions

BEHAVIORAL

Diabetic foot self-management support

Daily educational organic or inorganic posts (2 to 5) released in a timed sequence through a Hootsuite application plus peer interactions/support for three months.

Sponsors & Collaborators

  • Wounds Canada

    collaborator UNKNOWN

  • Helen Obilor

    lead OTHER

Principal Investigators

  • Helen N Obilor, MSc. · Faculty of Health Sciences\School of Nursing, Queen's University

  • Kevin Woo, Ph.D. · Faculty of Health Sciences\School of Nursing, Queen's University

  • Rosemary Wilson, Ph.D. · Faculty of Health Sciences\School of Nursing, Queen's University

  • Joan E Tranmer, Ph.D · Faculty of Health Sciences\School of Nursing, Queen's University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-16
Primary Completion
2021-10-30
Completion
2021-10-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04395521 on ClinicalTrials.gov